Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 2,800.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 11,429
  • Market Cap: £146.30m
  • Beta: 0.02

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
21.1% below the market average21.1% below the market average21.1% below the market average21.1% below the market average21.1% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
1yr Revenue Growth
13.04% above the market average13.04% above the market average13.04% above the market average13.04% above the market average13.04% above the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
44.04% above the market average44.04% above the market average44.04% above the market average44.04% above the market average44.04% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
36.54% below the market average36.54% below the market average36.54% below the market average36.54% below the market average36.54% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
41.00% above the market average41.00% above the market average41.00% above the market average41.00% above the market average41.00% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Price Book Ratio
93.95% below the market average93.95% below the market average93.95% below the market average93.95% below the market average93.95% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
54.12% above the market average54.12% above the market average54.12% above the market average54.12% above the market average54.12% above the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average
Price Chg 3m
14.45% below the market average14.45% below the market average14.45% below the market average14.45% below the market average14.45% below the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
16.57% above the market average16.57% above the market average16.57% above the market average16.57% above the market average16.57% above the market average
58.14% above the sector average58.14% above the sector average58.14% above the sector average58.14% above the sector average58.14% above the sector average
Momentum 20
94.19% above the market average94.19% above the market average94.19% above the market average94.19% above the market average94.19% above the market average
95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average95.35% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
75.00% above the market average75.00% above the market average75.00% above the market average75.00% above the market average75.00% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
ROCE
79.57% above the market average79.57% above the market average79.57% above the market average79.57% above the market average79.57% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.16% above the market average91.16% above the market average91.16% above the market average91.16% above the market average91.16% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Forecast EPS
76.92% above the market average76.92% above the market average76.92% above the market average76.92% above the market average76.92% above the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.6% below the market average35.6% below the market average35.6% below the market average35.6% below the market average35.6% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Operating Profit Loss
25.86% above the market average25.86% above the market average25.86% above the market average25.86% above the market average25.86% above the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
23.98% below the market average23.98% below the market average23.98% below the market average23.98% below the market average23.98% below the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average
Cash
9.77% below the market average9.77% below the market average9.77% below the market average9.77% below the market average9.77% below the market average
6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average6.38% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
76.84% below the market average76.84% below the market average76.84% below the market average76.84% below the market average76.84% below the market average
85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average85.71% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,800.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 11,429
Shares Issued 5.22m
Market Cap £146.30m
Beta 0.02

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.87% below the market average18.87% below the market average18.87% below the market average18.87% below the market average18.87% below the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
Price Trend
63.85% below the market average63.85% below the market average63.85% below the market average63.85% below the market average63.85% below the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Income
40.33% above the market average40.33% above the market average40.33% above the market average40.33% above the market average40.33% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
17.59% below the market average17.59% below the market average17.59% below the market average17.59% below the market average17.59% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 15-May-2025

Time Volume / Share Price
15:41 1,700 @ 2,900.00p
14:57 105 @ 2,840.00p
14:55 8 @ 2,700.00p
14:55 151 @ 2,774.00p
14:18 270 @ 2,725.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page